Regina Buerck

Exec Asst at Anacor Pharmaceuticals - Palo Alto, California, United States

Regina Buerck's Colleagues at Anacor Pharmaceuticals
Sharon Kokubun

Accounting / Finance

Contact Sharon Kokubun

JIM MARCONI

V.P. Finance / Controller

Contact JIM MARCONI

Diane Larrea

Mgr, Financial Planning and Analysis

Contact Diane Larrea

Yasheen Zhou

Head of Computational Chemistry Group, Senior Research Fellow

Contact Yasheen Zhou

Ryan Walsh

VP, Chief Counsel IP & Litigation

Contact Ryan Walsh

Kevin Munoz

CEO

Contact Kevin Munoz

Ryan Sullivan

EVP, General Counsel & Secretary

Contact Ryan Sullivan

View All Regina Buerck's Colleagues
Regina Buerck's Contact Details
Email (Verified)
***@anacor.com
Get Regina Buerck's Email Address
Mobile Number
(XXX) XXX-XXXX
Get Regina Buerck's Mobile Number
HQ
["6505437500","6507390700","6505437660","16466168639","16505437575","2025573506","946085104500761","8326367517","113857184973023"]
Location
Company
Anacor Pharmaceuticals
Regina Buerck's Company Details
Anacor Pharmaceuticals logo, Anacor Pharmaceuticals contact details

Anacor Pharmaceuticals

Palo Alto, California, United States • 51 - 200 Employees
Pharmaceuticals

Anacor is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Anacor has discovered and is developing five clinical compounds, including its three lead programs: AN2690, a topical antifungal for the treatment of onychomycosis; AN2728, a topical anti-inflammatory PDE-4 inhibitor for the treatment of psoriasis; and GSK 2251052, or GSK '052 (formerly referred to as AN3365), a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria, which has been licensed to GlaxoSmithKline under the companies'​ research and development agreement. In addition, Anacor is developing AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections, and AN2898 as a topical anti-inflammatory product candidate for the treatment of psoriasis and atopic dermatitis.

Details about Anacor Pharmaceuticals
Frequently Asked Questions about Regina Buerck
Regina Buerck currently works for Anacor Pharmaceuticals.
Regina Buerck's role at Anacor Pharmaceuticals is Exec Asst.
Regina Buerck's email address is ***@anacor.com. To view Regina Buerck's full email address, please signup to ConnectPlex.
Regina Buerck works in the Pharmaceuticals industry.
Regina Buerck's colleagues at Anacor Pharmaceuticals are Sharon Kokubun, JIM MARCONI, Diane Larrea, Yasheen Zhou, Ryan Walsh, Kevin Munoz, Ryan Sullivan and others.
Regina Buerck's phone number is ["6505437500","6507390700","6505437660","16466168639","16505437575","2025573506","946085104500761","8326367517","113857184973023"]
See more information about Regina Buerck